The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy
Leigh Ellis(Prostate Cancer Research), Ricky W. Johnstone(Peter MacCallum Cancer Centre)
Cited by 112
Related Papers
New and emerging HDAC inhibitors for cancer treatment
|Journal of Clinical Investigation|2014|1.4k
BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
|Cell Reports|2017|297
T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments
|Nature|2016|205
Functional Crosstalk between Type I and II Interferon through the Regulated Expression of STAT1
|PLoS Biology|2010|196
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma
|Nature Communications|2021|167